Conbercept Ophthalmic not checked
Chengdu Kanghong Biotech Co., Ltd. · KH902
FollowEvery change as it happens, and a Monday email
Stage
No active trials
Next date
None yet
Trials
0 active
3 in total
Targets
—
None known yet
What this is
- How it works
- A decoy protein that soaks up a signal molecule before it can reach the body's cells.-cept: receptor molecules, native or modified WHO name stem
- How it’s given
- “Subject receive 0.5 mg Conbercept injection into their study eyes every month (Day 0 - Month 5). If subjects meets the criteria for repeated administration, the subject receives 0.5 mg Conbercept injection into the study eye (Month 6 \~ 11).”In the company’s words, NCT03223714 on ClinicalTrials.gov
- Tested for
- Macular Edema (2 trials), Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion, Retinoblastoma
- Main trialPhase 3
- “This study evaluates the efficacy and safety of Conbercept ophthalmic injection. This is a multi-center, randomized, double-masked, placebo-controlled phase III clinical study. 237 patients with central retinal vein occlusion(CRVO) are expected to be enrolled in the study and randomly assigned into the Conbercept ophthalmic injection treatment group or the control group at a ratio of 2:1.”In the company’s words, NCT03223714 on ClinicalTrials.gov
- Other names
- KH902
Other drugs for Macular Edema
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Completed | 13 Apr 2020 | Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion | |
| Phase 3Completed | 13 Apr 2020 | Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion | |
| Phase 2Unknown | 15 Apr 2023 | A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026